Results 111 to 120 of about 545,250 (204)

Inhibition of tumor–microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain [PDF]

, 2018
Grither, Whitney R., Longmore, Gregory D.   +1 more
core   +1 more source

Combined targeting poly (ADP-ribose) polymerase and receptor tyrosine kinase inhibits ovarian clear cell carcinoma progression through disrupted ribosome biogenesis. [PDF]

J Mol Med (Berl)
Lin CY, Chao AS, Chao A, Wu RC, Yu AL, Fu CH, Teng YC, Huang RY, Lai CH.   +8 more
europepmc   +1 more source

Multivalent DNA Origami Enables Single-Molecule Dissection of Integrin αvβ6-Receptor Tyrosine Kinase Crosstalk in Cancer Biology. [PDF]

ACS Nano
Zheng T, Rigby LG, Marshall JF, Palma M.
europepmc   +1 more source

Insulin receptor tyrosine kinase substrate in health and disease (Review). [PDF]

Mol Med Rep
Zhang X, Zhang Z.
europepmc   +1 more source

Structures and pH-dependent dimerization of the sevenless receptor tyrosine kinase. [PDF]

Mol Cell
Cerutti G, Arias R, Bahna F, Mannepalli S, Katsamba PS, Ahlsen G, Kloss B, Bruni R, Tomlinson A, Shapiro L.   +9 more
europepmc   +1 more source

A live-cell biosensor of in vivo receptor tyrosine kinase activity reveals feedback regulation of a developmental gradient. [PDF]

Cell Rep
Ho EK, Kim-Yip RP, Simpkins AG, Farahani PE, Oatman HR, Posfai E, Shvartsman SY, Toettcher JE.   +7 more
europepmc   +1 more source

Drug-drug interactions between epidermal growth factor receptor tyrosine kinase inhibitors and rivaroxaban in vitro and in vivo. [PDF]

PLoS One
Wang D, Wang S, Wu H, Geng P, An Y, Zhou X, Du M, Li Y, Chong J, Li Y, Wang F, Lu Z, Wang Y, Yang J, Li C, Dai D, Chen H.   +16 more
europepmc   +1 more source

Receptor Tyrosine Kinase Inhibition [PDF]

, 2020
openaire   +1 more source

Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial.

JMIR Res Protoc
Hao S, Li X, Hao S, Zhang X, Qi X, Jin G, Shen F, Liu L.   +7 more
europepmc   +1 more source

Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high-risk KMT2A-rearranged acute myeloid leukaemia. [PDF]

Br J Haematol
Chavan A, Frett B, Armstrong DT, Acharya B, Lockyer P, Boerma M, Roy Choudhury S.   +6 more
europepmc   +1 more source